Clinical Trial Update: A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of SIM0505 in participants with advanced solid tumors is currently recruiting. The sponsor is NextCure, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SIM0505

Snippet

Sponsor: NextCure, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING